Global Prostate Cancer Treatment Drugs Market Growth (Status and Outlook) 2024-2030

2024

Global Prostate Cancer Treatment Drugs Market Growth (Status and Outlook) 2024-2030

Name: Global Prostate Cancer Treatment Drugs Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001245
Price: 3950 USD
Availability: InStock
Rating: 5 (15.6 reviews)

The global prostate cancer treatment drugs market is valued at US$ 14.00 billion in 2024, with growing demand for effective cancer therapies.

Bonafide Trust
12-09-2024
Pages : 88
Figures : 79
Tables : 92
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global prostate cancer treatment drugs market has witnessed significant growth over recent years, driven by an increasing prevalence of prostate cancer, especially in the aging male population. As one of the most common cancers among men worldwide, prostate cancer has become a major focus for pharmaceutical research and development. This disease is more likely to affect men over the age of 50, and with the growing global population, the incidence is expected to continue rising. As a result, there has been an increasing demand for more effective prostate cancer treatments that offer better survival rates, improved quality of life, and fewer side effects. The development of new drugs and treatment regimens, such as targeted therapies, immunotherapies, and hormone therapies, has revolutionized the prostate cancer treatment landscape. Additionally, advances in early detection and diagnosis have enabled healthcare professionals to intervene at earlier stages of the disease, increasing the success rates of treatment. The global market for prostate cancer treatment drugs is further fueled by increased awareness, early screening programs, and better healthcare access, which have collectively led to a greater number of patients seeking treatment. Furthermore, ongoing research, collaborations between pharmaceutical companies, and investments in new drug discoveries are driving the continuous innovation of treatment options. With a growing portfolio of therapies, the market is evolving to provide more personalized and effective treatments, which are expected to continue to grow as new molecules and combinations of drugs are developed.

According to Publisher, global Prostate Cancer Treatment Drugs market size was valued at US$ 14000 million in 2024. With growing demand in downstream market, the Prostate Cancer Treatment Drugs is forecast to a readjusted size of US$ 18610 million by 2030 with a CAGR of 4.1% during review period. North America remains the largest market for prostate cancer treatment drugs, driven by the region's advanced healthcare infrastructure, well-established medical practices, and high rates of healthcare spending. The United States, in particular, is a significant player in this market, with a large patient population and strong adoption of novel therapies. The availability of cutting-edge treatments, along with a robust pharmaceutical industry, has made the U.S. a leader in prostate cancer drug development and distribution. With a high incidence of prostate cancer and increasing awareness about the disease, the demand for prostate cancer drugs in North America is expected to remain strong. In addition to North America, Europe has seen considerable growth in the market for prostate cancer treatments, driven by factors such as an aging population and advancements in medical technology. Countries such as Germany, the United Kingdom, and France are expected to witness continued market expansion, as government policies increasingly support the availability of advanced cancer therapies and reimbursement options for prostate cancer treatments. The Asia Pacific region, particularly China, India, and Japan, is poised to experience substantial growth due to increasing healthcare investments, rising awareness, and expanding access to treatments. The market in these regions is also supported by a growing emphasis on cancer care, with prostate cancer becoming a priority for healthcare providers. In emerging markets such as Latin America, the Middle East, and Africa, improvements in healthcare infrastructure and an increasing focus on cancer care are contributing to the growth of the prostate cancer treatment drugs market. As these regions continue to modernize their healthcare systems, the demand for effective prostate cancer treatments is expected to rise, supporting the global market's expansion.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global prostate cancer treatment drugs market can be segmented by the types of drugs available for treatment. The main categories include hormone therapies, chemotherapy, immunotherapy, targeted therapies, and other treatments. Hormone therapies, or androgen deprivation therapies (ADT), remain the most commonly used treatment for prostate cancer. These drugs work by lowering levels of male hormones such as testosterone, which fuel the growth of prostate cancer cells. Hormone therapy can be used in combination with other treatments for patients with advanced or metastatic prostate cancer. Chemotherapy is often prescribed to patients with advanced or metastatic prostate cancer that is no longer responsive to hormone therapy. Chemotherapy involves the use of drugs that kill rapidly dividing cancer cells, although it can also affect healthy cells, leading to side effects. Immunotherapy is an emerging class of drugs that helps to enhance the body’s immune system to attack cancer cells. Immune checkpoint inhibitors and other immunotherapeutic agents are gaining popularity as they show potential for providing long-term remission in some patients. Targeted therapies are drugs that focus on specific molecules or genetic mutations involved in the growth of cancer cells. These therapies allow for a more personalized treatment approach with fewer side effects compared to traditional chemotherapy. Other drug categories, including bone-targeting agents and vaccines, are also contributing to the growing treatment options available for prostate cancer patients. The increasing use of combination therapies and the development of new drug classes are expected to drive further growth in the prostate cancer treatment drugs market. As research continues, more targeted and effective therapies will emerge, improving outcomes for patients and expanding the available treatment options.

The prostate cancer treatment drugs market can also be segmented based on the application of treatment, particularly in relation to the stage of cancer at diagnosis. Prostate cancer is typically diagnosed in one of three stages: localized, locally advanced, or metastatic. For localized prostate cancer, which is confined to the prostate gland, treatment typically involves surgery, radiation therapy, or active surveillance, with drugs being used for tumor shrinkage or to reduce the risk of recurrence. While localized prostate cancer often has a favorable prognosis, treatment decisions are influenced by factors such as the patient's age, overall health, and tumor characteristics. Locally advanced prostate cancer refers to cancer that has spread beyond the prostate but has not yet reached distant organs. This stage may involve the use of a combination of therapies, including surgery, radiation, and drugs such as hormone therapies or chemotherapy to control tumor growth and reduce the risk of metastasis. For metastatic prostate cancer, where cancer has spread to other parts of the body, treatment becomes more complex and requires a multifaceted approach. Hormone therapy is commonly used for metastatic prostate cancer, but chemotherapy, immunotherapy, and targeted therapies may also be utilized. The goal at this stage is to control the disease, reduce symptoms, and prolong survival. Metastatic prostate cancer is particularly challenging to treat, and ongoing therapy is often necessary to manage the disease. As research into the molecular and genetic underpinnings of prostate cancer progresses, the development of personalized treatment options based on the stage of the disease is expected to further enhance patient outcomes. The focus on stage-specific treatments and the introduction of new drug classes will continue to play a major role in the expansion of the prostate cancer treatment drugs market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Treatment Drugs Market Size 2019-2030
2.1.2 Prostate Cancer Treatment Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Prostate Cancer Treatment Drugs Segment by Type
2.2.1 Zytiga
2.2.2 Gonax
2.2.3 Lupron
2.2.4 Zoladex
2.2.5 Decapeptyl
2.2.6 Eligard
2.2.7 Vantas
2.2.8 Casodex
2.2.9 Others
2.3 Prostate Cancer Treatment Drugs Market Size by Type
2.3.1 Prostate Cancer Treatment Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Prostate Cancer Treatment Drugs Market Size Market Share by Type (2019-2024)
2.4 Prostate Cancer Treatment Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Clinics
2.5 Prostate Cancer Treatment Drugs Market Size by Application
2.5.1 Prostate Cancer Treatment Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Prostate Cancer Treatment Drugs Market Size Market Share by Application (2019-2024)
3 Prostate Cancer Treatment Drugs Market Size by Player
3.1 Prostate Cancer Treatment Drugs Market Size Market Share by Players
3.1.1 Global Prostate Cancer Treatment Drugs Revenue by Players (2019-2024)
3.1.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Cancer Treatment Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Prostate Cancer Treatment Drugs by Regions
4.1 Prostate Cancer Treatment Drugs Market Size by Regions (2019-2024)
4.2 Americas Prostate Cancer Treatment Drugs Market Size Growth (2019-2024)
4.3 APAC Prostate Cancer Treatment Drugs Market Size Growth (2019-2024)
4.4 Europe Prostate Cancer Treatment Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Prostate Cancer Treatment Drugs Market Size Growth (2019-2024)
5 Americas
5.1 Americas Prostate Cancer Treatment Drugs Market Size by Country (2019-2024)
5.2 Americas Prostate Cancer Treatment Drugs Market Size by Type (2019-2024)
5.3 Americas Prostate Cancer Treatment Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostate Cancer Treatment Drugs Market Size by Region (2019-2024)
6.2 APAC Prostate Cancer Treatment Drugs Market Size by Type (2019-2024)
6.3 APAC Prostate Cancer Treatment Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Prostate Cancer Treatment Drugs by Country (2019-2024)
7.2 Europe Prostate Cancer Treatment Drugs Market Size by Type (2019-2024)
7.3 Europe Prostate Cancer Treatment Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Treatment Drugs by Region (2019-2024)
8.2 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Prostate Cancer Treatment Drugs Market Forecast
10.1 Global Prostate Cancer Treatment Drugs Forecast by Regions (2025-2030)
10.1.1 Global Prostate Cancer Treatment Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Prostate Cancer Treatment Drugs Forecast
10.1.3 APAC Prostate Cancer Treatment Drugs Forecast
10.1.4 Europe Prostate Cancer Treatment Drugs Forecast
10.1.5 Middle East & Africa Prostate Cancer Treatment Drugs Forecast
10.2 Americas Prostate Cancer Treatment Drugs Forecast by Country (2025-2030)
10.2.1 United States Prostate Cancer Treatment Drugs Market Forecast
10.2.2 Canada Prostate Cancer Treatment Drugs Market Forecast
10.2.3 Mexico Prostate Cancer Treatment Drugs Market Forecast
10.2.4 Brazil Prostate Cancer Treatment Drugs Market Forecast
10.3 APAC Prostate Cancer Treatment Drugs Forecast by Region (2025-2030)
10.3.1 China Prostate Cancer Treatment Drugs Market Forecast
10.3.2 Japan Prostate Cancer Treatment Drugs Market Forecast
10.3.3 Korea Prostate Cancer Treatment Drugs Market Forecast
10.3.4 Southeast Asia Prostate Cancer Treatment Drugs Market Forecast
10.3.5 India Prostate Cancer Treatment Drugs Market Forecast
10.3.6 Australia Prostate Cancer Treatment Drugs Market Forecast
10.4 Europe Prostate Cancer Treatment Drugs Forecast by Country (2025-2030)
10.4.1 Germany Prostate Cancer Treatment Drugs Market Forecast
10.4.2 France Prostate Cancer Treatment Drugs Market Forecast
10.4.3 UK Prostate Cancer Treatment Drugs Market Forecast
10.4.4 Italy Prostate Cancer Treatment Drugs Market Forecast
10.4.5 Russia Prostate Cancer Treatment Drugs Market Forecast
10.5 Middle East & Africa Prostate Cancer Treatment Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Prostate Cancer Treatment Drugs Market Forecast
10.5.2 South Africa Prostate Cancer Treatment Drugs Market Forecast
10.5.3 Israel Prostate Cancer Treatment Drugs Market Forecast
10.5.4 Turkey Prostate Cancer Treatment Drugs Market Forecast
10.5.5 GCC Countries Prostate Cancer Treatment Drugs Market Forecast
10.6 Global Prostate Cancer Treatment Drugs Forecast by Type (2025-2030)
10.7 Global Prostate Cancer Treatment Drugs Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Prostate Cancer Treatment Drugs Product Offered
11.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 Astella
11.2.1 Astella Company Information
11.2.2 Astella Prostate Cancer Treatment Drugs Product Offered
11.2.3 Astella Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Astella Main Business Overview
11.2.5 Astella Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Prostate Cancer Treatment Drugs Product Offered
11.3.3 Sanofi Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Ipsen
11.4.1 Ipsen Company Information
11.4.2 Ipsen Prostate Cancer Treatment Drugs Product Offered
11.4.3 Ipsen Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Ipsen Main Business Overview
11.4.5 Ipsen Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Prostate Cancer Treatment Drugs Product Offered
11.5.3 Bayer Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Prostate Cancer Treatment Drugs Product Offered
11.6.3 AstraZeneca Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Dendreon
11.7.1 Dendreon Company Information
11.7.2 Dendreon Prostate Cancer Treatment Drugs Product Offered
11.7.3 Dendreon Prostate Cancer Treatment Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Dendreon Main Business Overview
11.7.5 Dendreon Latest Developments
12 Research Findings and Conclusion

Table 1. Prostate Cancer Treatment Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Zytiga
Table 3. Major Players of Gonax
Table 4. Major Players of Lupron
Table 5. Major Players of Zoladex
Table 6. Major Players of Decapeptyl
Table 7. Major Players of Eligard
Table 8. Major Players of Vantas
Table 9. Major Players of Casodex
Table 10. Major Players of Others
Table 11. Prostate Cancer Treatment Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 13. Global Prostate Cancer Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 14. Prostate Cancer Treatment Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 15. Global Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 16. Global Prostate Cancer Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 17. Global Prostate Cancer Treatment Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 18. Global Prostate Cancer Treatment Drugs Revenue Market Share by Player (2019-2024)
Table 19. Prostate Cancer Treatment Drugs Key Players Head office and Products Offered
Table 20. Prostate Cancer Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Prostate Cancer Treatment Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 24. Global Prostate Cancer Treatment Drugs Market Size Market Share by Regions (2019-2024)
Table 25. Global Prostate Cancer Treatment Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 26. Global Prostate Cancer Treatment Drugs Revenue Market Share by Country/Region (2019-2024)
Table 27. Americas Prostate Cancer Treatment Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 28. Americas Prostate Cancer Treatment Drugs Market Size Market Share by Country (2019-2024)
Table 29. Americas Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 30. Americas Prostate Cancer Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 31. Americas Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 32. Americas Prostate Cancer Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 33. APAC Prostate Cancer Treatment Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 34. APAC Prostate Cancer Treatment Drugs Market Size Market Share by Region (2019-2024)
Table 35. APAC Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 36. APAC Prostate Cancer Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 37. APAC Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 38. APAC Prostate Cancer Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 39. Europe Prostate Cancer Treatment Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 40. Europe Prostate Cancer Treatment Drugs Market Size Market Share by Country (2019-2024)
Table 41. Europe Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 42. Europe Prostate Cancer Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 43. Europe Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 44. Europe Prostate Cancer Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 45. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Prostate Cancer Treatment Drugs Market Size Market Share by Region (2019-2024)
Table 47. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 48. Middle East & Africa Prostate Cancer Treatment Drugs Market Size Market Share by Type (2019-2024)
Table 49. Middle East & Africa Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 50. Middle East & Africa Prostate Cancer Treatment Drugs Market Size Market Share by Application (2019-2024)
Table 51. Key Market Drivers & Growth Opportunities of Prostate Cancer Treatment Drugs
Table 52. Key Market Challenges & Risks of Prostate Cancer Treatment Drugs
Table 53. Key Industry Trends of Prostate Cancer Treatment Drugs
Table 54. Global Prostate Cancer Treatment Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 55. Global Prostate Cancer Treatment Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 56. Global Prostate Cancer Treatment Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 57. Global Prostate Cancer Treatment Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 58. Johnson & Johnson Details, Company Type, Prostate Cancer Treatment Drugs Area Served and Its Competitors
Table 59. Johnson & Johnson Prostate Cancer Treatment Drugs Product Offered
Table 60. Johnson & Johnson Prostate Cancer Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Johnson & Johnson Main Business
Table 62. Johnson & Johnson Latest Developments
Table 63. Astella Details, Company Type, Prostate Cancer Treatment Drugs Area Served and Its Competitors
Table 64. Astella Prostate Cancer Treatment Drugs Product Offered
Table 65. Astella Main Business
Table 66. Astella Prostate Cancer Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Astella Latest Developments
Table 68. Sanofi Details, Company Type, Prostate Cancer Treatment Drugs Area Served and Its Competitors
Table 69. Sanofi Prostate Cancer Treatment Drugs Product Offered
Table 70. Sanofi Main Business
Table 71. Sanofi Prostate Cancer Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Sanofi Latest Developments
Table 73. Ipsen Details, Company Type, Prostate Cancer Treatment Drugs Area Served and Its Competitors
Table 74. Ipsen Prostate Cancer Treatment Drugs Product Offered
Table 75. Ipsen Main Business
Table 76. Ipsen Prostate Cancer Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Ipsen Latest Developments
Table 78. Bayer Details, Company Type, Prostate Cancer Treatment Drugs Area Served and Its Competitors
Table 79. Bayer Prostate Cancer Treatment Drugs Product Offered
Table 80. Bayer Main Business
Table 81. Bayer Prostate Cancer Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bayer Latest Developments
Table 83. AstraZeneca Details, Company Type, Prostate Cancer Treatment Drugs Area Served and Its Competitors
Table 84. AstraZeneca Prostate Cancer Treatment Drugs Product Offered
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Prostate Cancer Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. AstraZeneca Latest Developments
Table 88. Dendreon Details, Company Type, Prostate Cancer Treatment Drugs Area Served and Its Competitors
Table 89. Dendreon Prostate Cancer Treatment Drugs Product Offered
Table 90. Dendreon Main Business
Table 91. Dendreon Prostate Cancer Treatment Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Dendreon Latest Developments

Figure 1. Prostate Cancer Treatment Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Cancer Treatment Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Prostate Cancer Treatment Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Prostate Cancer Treatment Drugs Sales Market Share by Country/Region (2023)
Figure 8. Prostate Cancer Treatment Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Prostate Cancer Treatment Drugs Market Size Market Share by Type in 2023
Figure 10. Prostate Cancer Treatment Drugs in Hospitals
Figure 11. Global Prostate Cancer Treatment Drugs Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Prostate Cancer Treatment Drugs in Ambulatory Surgical Centers
Figure 13. Global Prostate Cancer Treatment Drugs Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 14. Prostate Cancer Treatment Drugs in Clinics
Figure 15. Global Prostate Cancer Treatment Drugs Market: Clinics (2019-2024) & ($ Millions)
Figure 16. Global Prostate Cancer Treatment Drugs Market Size Market Share by Application in 2023
Figure 17. Global Prostate Cancer Treatment Drugs Revenue Market Share by Player in 2023
Figure 18. Global Prostate Cancer Treatment Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Prostate Cancer Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Prostate Cancer Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Prostate Cancer Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Prostate Cancer Treatment Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Prostate Cancer Treatment Drugs Value Market Share by Country in 2023
Figure 24. United States Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Prostate Cancer Treatment Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Prostate Cancer Treatment Drugs Market Size Market Share by Type in 2023
Figure 30. APAC Prostate Cancer Treatment Drugs Market Size Market Share by Application in 2023
Figure 31. China Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Prostate Cancer Treatment Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Prostate Cancer Treatment Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Prostate Cancer Treatment Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Prostate Cancer Treatment Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Prostate Cancer Treatment Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Prostate Cancer Treatment Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Prostate Cancer Treatment Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 68. France Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Prostate Cancer Treatment Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Prostate Cancer Treatment Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Prostate Cancer Treatment Drugs Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted